Cargando…

Analysis of the trends of polypharmacy and high‐dose prescriptions in Japan

INTRODUCTION: After extensive research, this study explored whether high‐dose prescriptions and polypharmacy remain more frequent in Japan than elsewhere. If confirmed, we aimed to identify the factors that contributed to this unique trend. METHODS: The psychotropic drug prescription patterns for pa...

Descripción completa

Detalles Bibliográficos
Autor principal:	Shinfuku, Naotaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285042/ https://www.ncbi.nlm.nih.gov/pubmed/34519433 http://dx.doi.org/10.1111/appy.12488

Ejemplares similares

Prescription patterns in psychiatric compulsory care: polypharmacy and high-dose antipsychotics
por: Kaikoushi, Katerina, et al.
Publicado: (2021)

Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan
por: Sukegawa, Tsuruhei, et al.
Publicado: (2014)

Differences in High Dose Antipsychotic Prescriptions in Patients with Schizophrenia in Asian Countries/Areas: Findings from the REAP-AP Study
por: Park, Yong Chon, et al.
Publicado: (2018)

Prescription pattern of antidepressants in five tertiary care psychiatric centres of India
por: Tripathi, Adarsh, et al.
Publicado: (2016)

A comparative study of food habits and body shape perception of university students in Japan and Korea
por: Sakamaki, Ruka, et al.
Publicado: (2005)

Prescription Patterns for Patients with Schizophrenia in Korea: A Focus on Antipsychotic Polypharmacy
por: Kim, Hee-Yun, et al.
Publicado: (2014)

Examining Patterns of Polypharmacy in Bipolar Disorder: Findings from the REAP-BD, Korea
por: Kim, Kiwon, et al.
Publicado: (2019)

Polypharmacy Pattern in Iran: A Comprehensive Analysis of a Large Prescription Database
por: Ebrahimoghli, Reza, et al.
Publicado: (2023)

Incidence of and Ivermectin Prescription Trends for COVID-19 in Japan
por: Watari, Takashi, et al.
Publicado: (2022)

Medication discrepancies and potentially inadequate prescriptions in elderly adults with polypharmacy in ambulatory care
por: Franco, Juan Víctor Ariel, et al.
Publicado: (2017)

Prescription Advice Based on Data of Drug-Drug-Gene Interaction of Patients with Polypharmacy
por: Salamone, Sandro, et al.
Publicado: (2022)

Prevalence and Prescription of Antidepressants in Depression with Somatic Comorbidity in Asia: The Research on East Asian Psychotropic Prescription Patterns Study
por: Chen, Chao, et al.
Publicado: (2015)

Changes in medicine prescription following a medication review in older high-risk patients with polypharmacy
por: Hurmuz, Marian Z. M., et al.
Publicado: (2018)

Comprehension of Prescriptions and Errors in Taking Prescribed Medicines by Veterans – Polypharmacy a Problem Underrated
por: Singhal, Anuj, et al.
Publicado: (2021)

Use of Chronic Prescription Medications and Prevalence of Polypharmacy in Survivors of Childhood Cancer
por: Ewig, Celeste L. Y., et al.
Publicado: (2021)

2163 Polypharmacy and patterns of prescription medication use among cancer survivors
por: Murphy, Caitlin, et al.
Publicado: (2018)

A Call for a Rational Polypharmacy Policy: International Insights From Psychiatrists
por: Nakagami, Yukako, et al.
Publicado: (2021)

Prescription Drug Use and Polypharmacy Among Medicaid-Enrolled Adults with Autism: A Retrospective Cross-Sectional Analysis
por: Vohra, Rini, et al.
Publicado: (2016)

Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
por: Yasui‐Furukori, Norio, et al.
Publicado: (2020)

Mapping Drug Prescription, Polypharmacy, and Pharmaceutical Spending in Older Adults in Iran: A Multilevel Analysis Based on Claims Data
por: Kamyari, Naser, et al.
Publicado: (2021)

Outpatient Prescriptions of Kampo Formulations in Japan
por: Yamana, Hayato, et al.
Publicado: (2020)

Prevalence and trends of polypharmacy in U.S. adults, 1999–2018
por: Wang, Xiaowen, et al.
Publicado: (2023)

High dose antipsychotic polypharmacy and dopamine partial agonists - time to rethink guidelines?
por: Reynolds, Gavin P
Publicado: (2021)

Effects of pharmacist intervention on polypharmacy in patients with type 2 diabetes in Japan
por: Horii, Takeshi, et al.
Publicado: (2020)

Hypnotic prescription trends and patterns for the treatment of insomnia in Japan: analysis of a nationwide Japanese claims database
por: Okuda, Shoki, et al.
Publicado: (2023)

Effects of medical service fee revision on reducing irrational psychotropic polypharmacy in Japan: an interrupted time-series analysis
por: Okada, Yusuke, et al.
Publicado: (2021)

Evaluation of the Individual Safe Correction of Antipsychotic Agent Polypharmacy in Japanese Patients with Chronic Schizophrenia: Validation of Safe Corrections for Antipsychotic Polypharmacy and the High-Dose Method
por: Yamanouchi, Yoshio, et al.
Publicado: (2015)

Analysis of hydroxychloroquine prescriptions for COVID‐19 in Japan
por: Watari, Takashi, et al.
Publicado: (2023)

Building interpretable models for polypharmacy prediction in older chronic patients based on drug prescription records
por: Kocbek, Simon, et al.
Publicado: (2018)

Prescription Patterns for Bipolar Disorder in Asian Countries: Findings from Research on Asian Prescription Pattern-Bipolar Disorder
por: Lin, Shih-Ku, et al.
Publicado: (2022)

Polypharmacy among the Elderly
por: Hosseini, Seyed Reza, et al.
Publicado: (2018)

An exploratory study of factors associated with long-term, high-dose opioid prescription in cancer patients in Japan based on a medical claims database
por: Hashimoto, Tatsuya, et al.
Publicado: (2022)

Trends in multimorbidity and polypharmacy in the Flemish-Belgian population between 2000 and 2015
por: van den Akker, Marjan, et al.
Publicado: (2019)

Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines
por: Jorge, April M., et al.
Publicado: (2018)

Nationwide Long-Term Evaluation of Polypharmacy Reduction Policies Focusing on Older Adults in Japan
por: Ishida, Takehiro, et al.
Publicado: (2022)

Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients: The Japan Adverse Drug Events Study
por: Ayani, Nobutaka, et al.
Publicado: (2021)

Trends in polypharmacy and potentially inappropriate medication (PIM) in older and middle‐aged people treated for diabetes
por: Oktora, Monika Pury, et al.
Publicado: (2020)

Polypharmacy: Misleading, but manageable
por: Bushardt, Reamer L, et al.
Publicado: (2008)

S204. REDUCTION OF ANTIPSYCHOTIC DOSES AND POLYPHARMACY: TWO COCHRANE REVIEWS
por: Leucht, Stefan, et al.
Publicado: (2020)

Prescription Rates, Polypharmacy and Prescriber Variability in Swiss General Practice—A Cross-Sectional Database Study
por: Rachamin, Yael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tpsvnagbknqds0dg1e077glfrj